Sobi Acquires Emapalumab and Related Assets
STOCKHOLM, June 12, 2019 -- (Healthcare Sales & Marketing Network) -- Swedish Orphan Biovitrum AB (publ) (Sobi) (STO:SOBI) has signed an agreement to acquire, from Novimmune's shareholders, a newly established company owning emapalumab and related assets... Biopharmaceuticals, Acquisitions Swedish Orphan Biovitrum, Sobi, Novimmune, emapalumab
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news